
Diabetes is a disease characterised by increased levels of sugar in the blood stream. Blood sugar is normally regulated by the hormone insulin. Diabetes occurs either when the pancreas fails to secrete insulin or the tissues of the body fail to respond correctly. Diabetes affects both young and old people.
Patients with diabetes are more likely to develop eye problems such as cataracts or glaucoma, but the principal threat to vision is through diabetic retinopathy. Most patients will have developed some signs of diabetic change in the retina after 20 years.
With time, diabetes affects the blood vessels of the retina, causing impaired circulation and weakness of the vessel walls. In the earliest phase of the disease, 'background diabetic retinopathy' - small dot-like haemorrhages - may be visible, but vision is not threatened.
If leakage from blood vessels progresses, the central macular area of the retina becomes swollen and visual symptoms develop. This appearance is described medically as macular oedema and this phase of the disease is known as 'diabetic maculopathy'. If left untreated, it may permanently damage central vision. Maculopathy is common in Type II diabetes, the form of the disease usually occurring later in life.
Sight may also be threatened by proliferative diabetic retinopathy, in which there is a serious danger of haemorrhage into the vitreous gel which fills the eye. The cause of proliferation is inadequate oxygenation of the tissues of the retina, sometimes referred to as 'ischaemia'. The retina responds by growing abnormal 'new vessels', which are both unhelpful and dangerous and their fragility results in sudden bleeding. This type of retinopathy is often seen in Type I diabetes and, without adequate screening, may go unnoticed until severe haemorrhage occurs.
The most serious form of diabetic retinopathy occurs when proliferation and bleeding result in scarring between the retina and the gel within the eye. Contracting scar tissue can pull the retina away from the eye wall, resulting in permanent blindness.
Modern screening methods will alert us to diabetic eye disease before the onset of symptoms. The decision to treat is made on the basis of clinical examination and special tests, including fluorescein angiography and OCT retinal scanning. Maculopathy threatening the centre of vision is treated with small numbers of laser burns, which 'dry up' the water-logged retina. Injections into the eye (for example steroid treatment) may also be helpful. Proliferative diabetic retinopathy is treated by the application of hundreds, or even thousands, of laser burns to the periphery of the retina. This reduces the volume of sick retina, whilst saving a blood supply for the important central macular area.
Bleeding into the vitreous of the eye may require vitrectomy, a surgical procedure in which the blood-stained gel is safely removed. Bleeding points are treated and laser applied to prevent the development of more abnormal 'new vessels'. Modern vitrectomy surgery has revolutionised the treatment of severe proliferative diabetic retinopathy, giving hope to the most desperate of cases.
At Optegra, we provide diabetic retinopathy treatment at our Birmingham, Manchester, Surrey (Guildford) and Solent (Hampshire, between Southampton and Portsmouth) eye hospitals. Our teams of specialist eye surgeons and doctors have years of hands on experience. They can offer expert diagnosis and tailor unique treatments to a patients exact requirements. The Birmingham, Solent and Surrey hospitals are all equipped with advanced medical technologies enabling us to offer the best quality diabetic retinopathy treatments available in the UK.
See the differences for yourself & make an informed decision
Read More
Phyllis Harper (Surgeon: Mr Jeffrey)
All the staff were professional and friendly and made me feel relaxed throu...